Company: MDCXW
Filing Date: 2025-09-11
Form Type: DRS
Source: 0001062993-25-015568
Chunk: 265

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-11
Form: DRS
Chunk 265
---
 set forth in the SEPA.

On March 10, 2025, the Company closed its Tier II Regulation A offering of $4.2 million. The Company issued 1,490,000 units at a price of $2.80 per unit. Each unit consisted of one common share of the Company and one warrant to purchase one common share. The warrants have an exercise price of $2.80 per share and will expire 5 years from the date of issuance.

<div align='center'>F-23</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

Medicus Pharma Ltd.
Condensed Consolidated Interim Financial Statements
For the three and six months ended June 30, 2025 and 2024
(unaudited)(expressed in United States dollars, except number of shares)

<div align='center'>F-24</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

<div align='center'>MEDICUS PHARMA LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS</div>

|                                                                                                                                                                        |   |    June 30, 
        2025 |   |   | December 31, 
         2024 |   |
|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--|------------:|:--|:--|-------------:|:--|
|                                                                                                                                                                        |   |  -unaudited |   |   |              |   |
| Assets                                                                                                                                                                 |   |             |   |   |              |   |
| Current assets:                                                                                                                                                        |   |             |   |   |              |   |
| Cash and cash equivalents                                                                                                                                              | $ |   9,669,546 |   | $ |    4,164,323 |   |
| Prepaid expenses and other current assets                                                                                                                              |   |   1,327,185 |   |   |    1,213,984 |   |
| Total current assets                                                                                                                                                   |   |  10,996,731 |   |   |    5,378,307 |   |
| Operating lease right-of-use assets                                                                                                                                    |   |     220,999 |   |   |      268,571 |   |
| Deferred issuance costs